The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemes...

por Hadji, Peyman, Stoetzer, Oliver, Decker, Thomas, Kurbacher, Christian M., Marmé, Frederik, Schneeweiss, Andreas, Mundhenke, Christoph, Distelrath, Andrea, Fasching, Peter A., Lux, Michael P., Lüftner, Diana, Janni, Wolfgang, Muth, Mathias, Kreuzeder, Julia, Quiering, Claudia, Grischke, Eva-Marie, Tesch, Hans
Publicado 2018

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor‐positive, human epidermal growth factor receptor 2‐negative locally advanced or meta...

por Tesch, Hans, Stoetzer, Oliver, Decker, Thomas, Kurbacher, Christian M., Marmé, Frederik, Schneeweiss, Andreas, Mundhenke, Christoph, Distelrath, Andrea, Fasching, Peter A., Lux, Michael P., Lüftner, Diana, Hadji, Peyman, Janni, Wolfgang, Muth, Mathias, Kreuzeder, Julia, Quiering, Claudia, Taran, Florin‐Andrei
Publicado 2018

The Endocrine Treatment Landscape for Patients with HR+ HER2− Early-stage Breast Cancer in Germany Before the Introduction of CDK4/6 Inhibitor Therapy – A Real-World Analysis

por Nabieva, Naiba, Altmann, Falk, Apel, Klaus, Baerens, Dirk-Toralf, Beha, Michaela, Belau, Antje, Busch, Steffi, Guth, Dagmar, Heinrich, Georg, Kreiss-Sender, Janine, Markmann, Susanne, Olbermann, Andreas, Oskay-Özcelik, Gülten, Schuback, Beatrix, Steinfeld-Birg, Dieter, Quiering, Claudia, Kiss, Ferenc, Kreuzeder, Julia, Nuti, Paolo, Schilling, Jörg
Publicado 2023